[Prognosis of Kahler's disease in patients treated and not treated with alkylating agents (apropos of 45 cases)].
D000419:Albuminuria / Q000209:etiology; D001536:Bence Jones Protein / Q000032:analysis; D001859:Bone Neoplasms / Q000188:drug therapy*; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D005598:Fractures, Spontaneous / Q000209:etiology; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008558:Melphalan / Q000008:administration & dosage / Q000627:therapeutic use*; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy*; D010146:Pain; D011379:Prognosis
D005938:Glucocorticoids; D003520:Cyclophosphamide; D001536:Bence Jones Protein; D008558:Melphalan
Pronostic de la maladie de kahler chez des patients traités ou non par les agents alkylants (A propos de 45 cas.